The final report will offer context on chemical dependency offerings in Minnesota and include a benefit-cost analysis of treatment modalities. To estimate the impact of these treatments on client outcomes, MMB will draw from peer-reviewed, experimental design research conducted across the nation. In general, these studies find chemical dependency treatment to be effective at generating positive, cost-effective outcomes for clients. MMB will use the work to inform agency and legislative discussions of improving Minnesota's model of care.
For further information about Results First, watch our webinar. We recommend opening the link with Google Chrome or Internet Explorer.
To learn more about the initiative and read past benefit-cost analysis reports, visit our website: mn.gov/mmb/results-first/
For any other questions, please contact ResultsFirstMN@state.mn.us